<p>, /PRNewswire/ -- <strong>Robbins Geller Rudman &amp; Dowd LLP</strong> 律师事务所正在调查与 Travere Therapeutics, Inc. (NASDAQ: TVTX) 相关的潜在美国联邦证券法违规行为。</p>
<p><strong>如果您有可能协助 Travere 调查的信息，或者您是遭受损失的 Travere 投资者并希望了解更多信息，您可以在此提供您的信息：</strong></p>
<p><strong>https://www.rgrdlaw.com/cases-travere-therapeutics-inc-investigation-tvtx.html</strong></p>
<p><strong>您也可以拨打 800/449-4900 联系 Robbins Geller 的律师 J.C. Sanchez，或通过电子邮件联系 [email protected]。</strong></p>
<p><strong>公司简介：</strong> Travere 是一家生物制药公司，致力于为生活在美国的罕见肾脏和代谢疾病患者开发治疗方案。</p>
<p><strong>调查内容：</strong> Robbins Geller 正在调查 Travere 及其某些高管是否发表了重大虚假和/或误导性陈述，和/或遗漏了关于 Travere 业务和运营的重要信息。</p>
<p><strong>关于 Robbins Geller：</strong> Robbins Geller Rudman &amp; Dowd LLP 是全球领先的律师事务所之一，代表投资者进行证券欺诈和股东诉讼。我们的事务所连续五年中有四年在 ISS 证券集体诉讼服务排名中被评为第一，因为为投资者争取到最多的经济救济。在 2024 年，我们为证券相关集体诉讼案件为投资者追回了超过 25 亿美元的赔偿——这一数字超过了排名前五的其他律师事务所的总和，依据 ISS 数据。Robbins Geller 拥有 200 名律师，设有 10 个办公室，是全球最大的原告律师事务所之一，事务所的律师获得了历史上许多最大的证券集体诉讼赔偿，包括在 <em>In re Enron Corp. Sec. Litig.</em> 中创下的历史最高赔偿——72 亿美元。有关更多信息，请访问以下页面：</p>
<p><strong>https://www.rgrdlaw.com/services-litigation-securities-fraud.html</strong></p>
<p>过去的结果并不保证未来的结果。</p>
<p>服务可能由我们任何办公室的律师提供。</p>
<p>联系方式：</p>
<p>Robbins Geller Rudman &amp; Dowd LLP</p>
<p>J.C. Sanchez</p>
<p>655 W. Broadway, Suite 1900, San Diego, CA 92101</p>
<p>800-449-4900</p>
<p><strong>[email protected]</strong></p>
<p>来源 Robbins Geller Rudman &amp; Dowd LLP</p>
<p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTI4Jk5ld3NJdGVtSWQ9TEE3Mjg2MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjgwNzEwUFJfTkVXU19VU1BSX19fX19MQTcyODYx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTI4Jk5ld3NJdGVtSWQ9TEE3Mjg2MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjgwNzEwUFJfTkVXU19VU1BSX19fX19MQTcyODYx"/></p>

TVTX

<p>Robbins Geller Rudman & Dowd LLP 正在调查涉及 Travere Therapeutics, Inc.（纳斯达克股票代码：TVTX）的美国联邦证券法潜在违规行为。该公司正在研究 Travere 及其高管是否对公司的业务运营做出了重大虚假或误导性的陈述。遭受损失或拥有与调查相关信息的投资者被鼓励与该律师事务所联系</p>

<p>, /PRNewswire/ -- The law firm of <strong>Robbins Geller Rudman &amp; Dowd LLP</strong> is investigating potential violations of U.S. federal securities laws involving Travere Therapeutics, Inc. (NASDAQ: TVTX).</p>
<div class="lb-trans"><p>, /PRNewswire/ -- <strong>Robbins Geller Rudman &amp; Dowd LLP</strong> 律师事务所正在调查与 Travere Therapeutics, Inc. (NASDAQ: TVTX) 相关的潜在美国联邦证券法违规行为。</p>
</div><p><strong>If you have information that could assist in the Travere investigation or if you are a Travere investor who suffered a loss and would like to learn more, you can provide your information here:</strong></p>
<div class="lb-trans"><p><strong>如果您有可能协助 Travere 调查的信息，或者您是遭受损失的 Travere 投资者并希望了解更多信息，您可以在此提供您的信息：</strong></p>
</div><p><strong>https://www.rgrdlaw.com/cases-travere-therapeutics-inc-investigation-tvtx.html</strong></p>
<div class="lb-trans"><p><strong>https://www.rgrdlaw.com/cases-travere-therapeutics-inc-investigation-tvtx.html</strong></p>
</div><p><strong>You can also contact attorney J.C. Sanchez of Robbins Geller by calling 800/449-4900 or via e-mail at [email protected].</strong></p>
<div class="lb-trans"><p><strong>您也可以拨打 800/449-4900 联系 Robbins Geller 的律师 J.C. Sanchez，或通过电子邮件联系 [email protected]。</strong></p>
</div><p><strong>THE COMPANY:</strong> Travere is a biopharmaceutical company that develops therapies for people living with rare kidney and metabolic diseases in the United States.</p>
<div class="lb-trans"><p><strong>公司简介：</strong> Travere 是一家生物制药公司，致力于为生活在美国的罕见肾脏和代谢疾病患者开发治疗方案。</p>
</div><p><strong>THE INVESTIGATION:</strong> Robbins Geller is investigating whether Travere and certain of its executives made materially false and/or misleading statements and/or omitted material information regarding Travere's business and operations.</p>
<div class="lb-trans"><p><strong>调查内容：</strong> Robbins Geller 正在调查 Travere 及其某些高管是否发表了重大虚假和/或误导性陈述，和/或遗漏了关于 Travere 业务和运营的重要信息。</p>
</div><p><strong>ABOUT ROBBINS GELLER</strong>: Robbins Geller Rudman &amp; Dowd LLP is one of the world's leading law firms representing investors in securities fraud and shareholder litigation. Our Firm has been ranked #1 in the ISS Securities Class Action Services rankings for four out of the last five years for securing the most monetary relief for investors. In 2024, we recovered over $2.5 billion for investors in securities-related class action cases – more than the next five law firms combined, according to ISS. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs' firms in the world, and the Firm's attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in <em>In re Enron Corp. Sec. Litig.</em> Please visit the following page for more information:</p>
<div class="lb-trans"><p><strong>关于 Robbins Geller：</strong> Robbins Geller Rudman &amp; Dowd LLP 是全球领先的律师事务所之一，代表投资者进行证券欺诈和股东诉讼。我们的事务所连续五年中有四年在 ISS 证券集体诉讼服务排名中被评为第一，因为为投资者争取到最多的经济救济。在 2024 年，我们为证券相关集体诉讼案件为投资者追回了超过 25 亿美元的赔偿——这一数字超过了排名前五的其他律师事务所的总和，依据 ISS 数据。Robbins Geller 拥有 200 名律师，设有 10 个办公室，是全球最大的原告律师事务所之一，事务所的律师获得了历史上许多最大的证券集体诉讼赔偿，包括在 <em>In re Enron Corp. Sec. Litig.</em> 中创下的历史最高赔偿——72 亿美元。有关更多信息，请访问以下页面：</p>
</div><p><strong>https://www.rgrdlaw.com/services-litigation-securities-fraud.html</strong></p>
<div class="lb-trans"><p><strong>https://www.rgrdlaw.com/services-litigation-securities-fraud.html</strong></p>
</div><p>Past results do not guarantee future outcomes.</p>
<div class="lb-trans"><p>过去的结果并不保证未来的结果。</p>
</div><p>Services may be performed by attorneys in any of our offices.</p>
<div class="lb-trans"><p>服务可能由我们任何办公室的律师提供。</p>
</div><p>Contact:</p>
<div class="lb-trans"><p>联系方式：</p>
</div><p>Robbins Geller Rudman &amp; Dowd LLP</p>
<div class="lb-trans"><p>Robbins Geller Rudman &amp; Dowd LLP</p>
</div><p>J.C. Sanchez</p>
<div class="lb-trans"><p>J.C. Sanchez</p>
</div><p>655 W. Broadway, Suite 1900, San Diego, CA 92101</p>
<div class="lb-trans"><p>655 W. Broadway, Suite 1900, San Diego, CA 92101</p>
</div><p>800-449-4900</p>
<div class="lb-trans"><p>800-449-4900</p>
</div><p><strong>[email protected]</strong></p>
<div class="lb-trans"><p><strong>[email protected]</strong></p>
</div><p>SOURCE Robbins Geller Rudman &amp; Dowd LLP</p>
<div class="lb-trans"><p>来源 Robbins Geller Rudman &amp; Dowd LLP</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTI4Jk5ld3NJdGVtSWQ9TEE3Mjg2MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjgwNzEwUFJfTkVXU19VU1BSX19fX19MQTcyODYx" alt="" original-src="https://rt.prnewswire.com/rt.gif?NewsItemId=LA72861&amp;Transmission_Id=202601280710PR_NEWS_USPR_____LA72861&amp;DateId=20260128"/></p>

07:10 ET
			
			
				TVTX INVESTIGATION NOTICE: Robbins Geller Rudman & Dowd LLP Launches Investigation into Travere Therapeutics, Inc., and Encourages Investors and Potential Witnesses to Contact Law Firm

TVTX 调查通知：Robbins Geller Rudman & Dowd LLP 启动对 Travere Therapeutics, Inc.的调查，并鼓励投资者和潜在证人联系该律师事务所